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Banti's Syndrome: Case Report and Review of Literature 
S.N. Waqar,S.Jindhani,N. S. Baig,M. A. Waqar,F. W. Ismail,M. Tariq  ( Department of Medicine, The Aga 
Khan University ) 
Introduction  
In 1898 Banti described a disorder characterized by splenomegaly and hypersplenism, 
resulting in portal hypertension and anemia in the absence of hematological disease. 1 
Banti's syndrome is also known as non-cirrhotic portal hypertension (NCPH) in India and 
Idiopathic Portal Hypertension (IPH) in Japan. Hepatoportal sclerosis seems to be its 
counterpart in the United States. 2,3 Banti's syndrome is a disorder of unknown etiology, 
clinically characterized by portal hypertension (varices and portosystemic collateral 
vessels), splenomegaly, and anemia (hypersplenism). 3 It has been reported from Indian 
subcontinent. 4-6 In a Pakistani case series of portal hypertension, 18 out of 37 patients 
were found to have IPH as the etiology. 6 We report a case of Banti's syndrome in an 20-
year old girl presenting to us with anemia and splenomegaly. 
Case Report  
A 20 year old female was referred to us for the evaluation of symptomatic anemia. She 
also complained of longstanding dull, dragging left sided abdominal pain. Review of 
systems revealed menorrhagia. On examination she was a lean, pale-looking girl. There 
was no lymphadenopathy or icterus. She was afebrile, her vitals were stable and 
cardiovascular examination revealed a systolic flow murmur in the mitral area. Her liver 
was not palpable, however, she had massive splenomegaly with the splenic edge reaching 
just below the umbilicus. Laboratory data revealed pancytopenia (Hb=8.4 gm/dl, 
WBC=2200/mm3 with 67% PMN and 22% lymphocytes, Platelet = 35,000/mm3) and 
peripheral blood film showed anisocytosis and hypochromic microcytic anemia. Her 
coagulation profile was normal, as were her liver function tests. Anemia workup revealed 
iron deficiency and five serial malarial parasite tests were negative. Coomb's test and 
autoimmune profile were negative and hypercoagulable states were ruled out. Her 
hepatitis serology was negative and she had normal [(0)] 
ceruloplasmin and alpha-l antitrypsin levels. Her bone marrow revealed a cellular 
specimen showing all hematopoeitic cell lines and massive splenomegaly was confIrmed 
on CT Abdomen, which demonstrated a splenic size of 21.7 cm in cranio-caudal extent. 
Moreover, it showed large varices in the splenic hilum, gastro-splenic and gastro- 
pancreatic ligaments and cavernous transformation of the portal vein, indicative of portal 
hypertension (Figure 1 ). Her liver size and texture was normal on CT scan and there was 
no evidence of cirrhosis (Figure 2). Ultrasound Color Doppler demonstrated numerous 
patent collaterals resulting from this cavernous transformation, with a hepatoportal flow 
velocity of 24 cm/sec. Esophagogastroduodenoscopy and sigmoidoscopy were normal. A 
presumptive diagnosis of Banti's syndrome was made on the basis of pancytopenia, 
splenomegaly and non cirrhotic portal hypertension. She was put on iron and folate 
supplements. In addition, low dose propranolol was also started, to reduce portal 
pressures. Splenectomy was not considered as she has no evidence of active bleeding. 
Her blood counts improved on supportive medical management. 
Discussion  
Patients with Banti's syndrome may present with a long-standing mass in the left upper 
quandrant due to splenomegaly and consequences of hypersplenism, as did our patient, or 
they may present with one or more well- tolerated episodes of gastrointestinal variceal 
bleeds resulting from portal hypertension. 7 Development of jaundice, hepatic 
encephalopathy and ascites is uncommon and the liver function tests are preserved in 
majority of patients. 7 ,8 Anemia in these patients may be microcytic, hypochromic due 
to gastrointestinal blood loss or normocytic, normochromic due to hypersplenism. 7 Our 
patient had microcytic hypochromic anemia despite normal endoscopy. Thalasemia was 
ruled out by serum protein electrophoresis. Anemia in this patient could be multifactorial, 
with menorrhagic blood loss and nutritional deficiency compounding hypersplenism. 
Leukopenia (<4000/mm3) and thrombocytopenia (<50,000/mm3) may occur in these 
patients on account of increase in plasma volume and splanchnic pooling of the blood 
while the bone marrow is hypercellular. Symptomatic hypersplenism is rather rare and 
necessitates intervention. 7 Banti's syndrome is a rare disease in the West, although its 
incidence in other countries, such as Japan and India is relatively higher. 9 The condition 
has been commonly seen in people who are socioeconomically disadvantaged, both in 
India and Iran. 7,l0 Improved hygiene and standards of living could explain the relative 
rarity of the disease in the West and its declining incidence in Japan, indirectly 
suggesting a role of infection. 1 I The few studies done in the Indian subcontinent 
indicate a male predominance in contrast to the West and Japan, where the disease is 
more common in females. Furthermore it affects a much younger age group of patients, 
varying from 25 to 35 years. 7 The etiology of Banti's syndrome is not well- understood. 
A number of hypotheses have been proposed implicating the role of systemic or intra-
abdominal infections, relationship with hepatitis B virus, clotting abnormalities and 
chronic exposure to toxic substances such as arsenic leading to phlebosclerosis of small 
portal vessels. 7,12 Immunologic and immunogenetic hypotheses have also been 
proposed, supported by reduction in suppressor/cytotoxic T lymphocytes and 
predominant Th1 cells seen in this disorder. 7,13 The HLA-DR expression in portal 
microvessels may be an initiating factor leading to immunologic assault on portal 
microvessels. 14 Based on the above theories, Sarin et al. concluded that the disorder 
could develop in a genetically predisposed individual when prothrombotic events 
precipitated repeated microthrombotic insults in the small and medium branches of the 
portal vein. The main histopathologic findings are periportal fibrosis, intimal thickening 
of intrahepatic portal venous channels, obliteration of small portal venules and emergence 
of new aberrant portal venous channels. Although these abnormalities could be secondary 
to portal hypertension, it has been proposed that the vascular changes are the primary 
event that leads to portal hypertension. 8 The intrasplenic and portal vein pressures are 
markedly elevated in patients with Banti's syndrome, as are splenic and portal vein blood 
flow, suggestive of hyperdynamic circulatory state. On ultrasonography, the portosplenic 
axis is seen as dilated and patent, as was the case with our patient. Hepatic venography 
and radionuclide scintigraphy have been used to distinguish between this entity and 
cirrhosis. 6,7 CT portography and CT hepatic angiography have also been used to 
demonstrate the aberrant vessels in these patients. The key management issues in patients 
with Banti's are gastrointestinal hemorrhage and hypersplenism. For acutely bleeding 
patients, endoscopic sclerotherapy and variceal ligation are equally efficacious in 95% of 
patients and very few need to undergo emergency shunt surgery. Variceal recurrence has 
been reported in approximately 20% of patients, though only 3% of these bleed 
recurrently. Beta-blockers are efficacious in primary prophylaxis even in non-cirrhotic 
patients with portal hypertension. 7 Surgery is also indicated for patients with 
symptomatic hypersplenism -spontaneous bleeding episodes or severe anemia requiring 
transfusion or repeated splenic infarcts. Prognosis for patients with Banti's disease is 
excellent. Even in patients with acute variceal bleeds, the mortality is significantly lower 
than seen in cirrhotic patients. After successful eradication of such gastroesophageal 
varices, the 5-year survival is reported to be as high as 100%. 7 
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